The use of human leucocyte antigen class I transgenic mice to investigate human immune function

被引:10
作者
Faulkner, L [1 ]
Borysiewicz, LK [1 ]
Man, S [1 ]
机构
[1] Univ Wales Coll Med, Dept Med, Cardiff CF4 4XX, S Glam, Wales
关键词
HLA class I; transgenic mice; cytotoxic T cells; beta(2) microglobulin;
D O I
10.1016/S0022-1759(98)00162-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
HLA class I transgenic mice are a powerful research tool which have been used as models for human immune responses. This review describes the generation of the different HLA class I transgenic mice, the techniques used to improve expression of the transgene and use of the transgene product in immune responses. It also illustrates how HLA class I transgenic mice have provided insights into the nature of the allogeneic and xenogeneic response, the generation of CTL responses, the development of autoimmune diseases, and their use for the generation of anti-HLA class I antibodies. Despite these advances, the use of available HLA class I transgenic mice as models for human disease and immune responses has been limited. The development of new transgenic strains incorporating multiple human transgenes may allow the potential of HLA class I transgenic mice to be realised. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 85 条
[1]  
AIUTI A, 1995, IMMUNOGENETICS, V42, P368
[2]  
Alexander J, 1997, J IMMUNOL, V159, P4753
[3]  
Bakker ABH, 1997, INT J CANCER, V70, P302, DOI 10.1002/(SICI)1097-0215(19970127)70:3<302::AID-IJC10>3.0.CO
[4]  
2-H
[5]  
BARRA C, 1990, TRANSGENIC MICE AND MUTANTS IN MHC RESEARCH, P191
[6]  
BARRA C, 1993, J IMMUNOL, V150, P3681
[7]  
BARRA C, 1989, J IMMUNOL, V143, P3117
[8]   STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 [J].
BJORKMAN, PJ ;
SAPER, MA ;
SAMRAOUI, B ;
BENNETT, WS ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1987, 329 (6139) :506-512
[9]   Nomenclature for factors of the HLA system, 1996 [J].
Bodmer, JG ;
Marsh, SGE ;
Albert, ED ;
Bodmer, WF ;
Bontrop, RE ;
Charron, D ;
Dupont, B ;
Erlich, HA ;
Fauchet, R ;
Mach, B ;
Mayr, WR ;
Parham, P ;
Sasazuki, T ;
Schreuder, GMT ;
Strominger, JL ;
Svejgaard, A ;
Terasaki, PI .
TISSUE ANTIGENS, 1997, 49 (03) :297-321
[10]   Construction and characterisation of a recombinant vaccinia was expressing human papillomavirus proteins for immunotherapy of cervical cancer [J].
Boursnell, MEG ;
Rutherford, E ;
Hickling, JK ;
Rollinson, EA ;
Munro, AJ ;
Rolley, N ;
McLean, CS ;
Borysiewicz, LK ;
Vousden, K ;
Inglis, SC .
VACCINE, 1996, 14 (16) :1485-1494